Maria Laura Bisegna | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
INTEGRATION OF CD200, CD43 AND ROR1 IN MULTIPARAMETER FLOW CYTOMETRY (MFC) ROUTINE PANELS FOR THE DIFFERENTIAL DIAGNOSIS OF B-CELL LYMPHOPROLIFERATIVE DISORDERS (B-LPDS)	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2025
Red Blood Cell Distribution Width May Predict Drug-Induced Anemia and Prognosis in Patients Affected by Primary/Secondary Myelofibrosis Treated with Ruxolitinib	ONCOLOGY AND THERAPY	2025
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation	EUROPEAN JOURNAL OF HAEMATOLOGY	2024
Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report	FRONTIERS IN ONCOLOGY	2024
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia	JOURNAL OF CLINICAL MEDICINE	2024
Treatment free remission (TFR) after second-generation tyrosine kinase inhibitors (2G-TKIs) treatment in chronic myeloid leukemia (CML): from feasibility to safety	EXPERT OPINION ON DRUG SAFETY	2024
Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors	EXPERT OPINION ON PHARMACOTHERAPY	2024
Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia	CANCERS	2024
NG2 molecule expression in acute lymphoblastic leukemia B cells: a flow-cytometric marker for the rapid identification of KMT2A gene rearrangements	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2024
CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2024
CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2024
Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in Chronic myeloid leukemia (CML)	EXPERT REVIEW OF HEMATOLOGY	2024
Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New Compounds	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA	2023
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients	EXPERT REVIEW OF HEMATOLOGY	2022
Trapianto di cellule staminali	Ematologia Smart, Edizioni Idelson Gnocchi 1908	2022
Diagnostica di laboratorio e strumentale	Ematologia Smart, Edizioni Idelson Gnocchi 1908	2022
Reduced Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) colonization in a hematological-emergency setting during the coronavirus disease 2019 (COVID-19) pandemic	INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY	2022
CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions	CURRENT HEMATOLOGIC MALIGNANCY REPORTS	2022
RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort	BLOOD ADVANCES	2022
Utility of Flow Cytometry Ascitic Fluid Analysis for Rapid Diagnosis of B-Cell Peritoneal Lymphomatosis	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2022